resource library

The Mitra device, based on VAMS technology has advantages over DBS cards and filter paper in the areas of collection, processing, and bioanalysis. The Mitra device provides the key benefits of working with dried blood, but with a volumetrically accurate, stable dried blood sample that reduces the incidence of reworks. 

Over sixty references prove that Mitra devices are compatible with a wide rage of analytes from therapeutic drugs to DNA/RNA to biomarkers.  Download our analyte compatibility list to learn more. If you don't see your analyte of  interest contact one of our Microsampling Specialists and they'll be able to help.

Initial implementation requires an upfront investment and may disrupt existing workflow, depending on the current processes in place. However, any initial friction is well worth it - Mitra microsampling technology saves money  (e.g. no cold-chain shipping), labor (e.g. compatible with typical liquid handling instrumentation), and resources (e.g use non-clinical staff to collect specimens) over time while better allowing for future growth.

Mitra automation solutions are available that allow medium- and high-throughput labs to process hundreds or thousands of samples per day. Contact a Microsampling Specialist to learn more.

All storage recommendations should follow the specific assay’s stability data as it was validated by the laboratory performing the analysis. Most samples can be stored and shipped at room temperature. Your Microsampling Specialist can offer specialized guidance if needed.

Our customers have produced bridging data showing correlations between venous blood draws and fingerstick blood draws, but there is a dependence on the analytical workflow and the compounds to be analyzed. Different analytes are known to circulate differently in venous and capillary blood, so studies will need to be done for each individual analyte and assay.